Anti-SARS-COV-2 antibodies Amongst Asymptomatic Healthcare Workers and students of Tertiary Care hospital and Medical School in Pakistan
DOI:
https://doi.org/10.47672/ajhmn.746Keywords:
COVID 19, prevalence, Asymptomatic, Health WorkersAbstract
Introduction: Coronavirus emerged as a pandemic in 2019 with the SARS COV 2 virus infecting people worldwide. Although PCR successfully detected symptomatic patients, asymptomatic patients remained undetected due to limitation of resources. The objective of the study was to determine the prevalence of IgM and IgG antibodies in the faculty, staff, and MBBS students in Medical school and tertiary care hospital, Pakistan.
Material and Methods: A cross-sectional study was conducted on 500 asymptomatic healthy subjects, from September to December 2020 in Biochemistry department Shalamar Medical and Dental College (SMDC). Rapid antibody test was used to determine the presence of IgM and IgG antibodies in the subjects. Those found IgM positive were validated by COVID 19 detection by Polymerase Chain Reaction.
Results: Anti-SARS-COV 2 antibodies was observed in 19.6 % of 500 asymptomatic subjects. Significant reactive cases were identified in hospital staff (27.5%) compared to hospital faculty (23.4%), medical students (21.4%), college faculty (6.12%) followed by college staff (3.06%). Significant reactive cases (47.9%) were identified in middle age group i.e. between 31 to 45 years. IgG was more prevalent than IgM and 2% of the subjects showed coagulation disorders who were both IgG and IgM positive.
Conclusion: Prevalence of 19.6% of Anti-SARS-COV 2 antibodies was observed in asymptomatic subjects. Prevalence was more in males, people in the middle age group i.e. 31 to 45 years and in hospital staff and faculty.
Recommendations: Based on the study it is recommended that Rapid COVID 19- SRAC-2 antibody test, which is cost effective and rapid method may be used to detect the COVID 19 in developing countries with limited resources.
Downloads
References
World Health Organization. (2020). World Health Organization coronavirus disease 2019 (COVID-19) situation report.
Zaidi, S., Rizwan, F., Riaz, Q., Siddiqui, A., Khawaja, S., Imam, M., ... & Shamsi, T. (2020). Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi—challenges in acquiring herd immunity for COVID 19. Journal of public health (Oxford, England).
Abid, K., Bari, Y. A., Younas, M., Tahir Javaid, S., & Imran, A. (2020). <? covid19?> Progress of COVID-19 Epidemic in Pakistan. Asia Pacific Journal of Public Health, 32(4), 154-156.
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., ... & Ye, F. (2020). Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. Journal of medical virology, 92(9), 1518-1524.
Chen, Y. M. A., Liang, S. Y., Shih, Y. P., Chen, C. Y., Lee, Y. M., Chang, L., ... & Chu, D. C. (2006). Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. Journal of clinical microbiology, 44(2), 359-365.
Liu, J., Liao, X., Qian, S., Yuan, J., Wang, F., Liu, Y., ... & Zhang, Z. (2020). Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerging infectious diseases, 26(6), 1320.
De Wit, E., Van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology, 14(8), 523.
Peeling, R. W., Wedderburn, C. J., Garcia, P. J., Boeras, D., Fongwen, N., Nkengasong, J., ... & Heymann, D. L. (2020). Serology testing in the COVID-19 pandemic response. The Lancet Infectious Diseases.
Zheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., ... & Liang, T. (2020). Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. Bmj, 369.
Zheng, J. (2020). SARS-CoV-2: an emerging coronavirus that causes a global threat. International journal of biological sciences, 16(10), 1678.
World Health Organization. (2020). Advice on the use of point-of-care immunodiagnostic tests for COVID-19: scientific brief, 8 April 2020 (No. WHO/2019-nCoV/Sci_Brief/POC_immunodiagnostics/2020.1). World Health Organization.
Pan American Health Organization. Advice on the use of point-of-care immunodiagnostic tests for COVID-19. April 8, 2020. https://covid19-evidence.paho.org/handle/20.500.12663/989.
Abid, K., Bari, Y. A., Younas, M., Tahir Javaid, S., & Imran, A. (2020). <? covid19?> Progress of COVID-19 Epidemic in Pakistan. Asia Pacific Journal of Public Health, 32(4), 154-156.
Walk, J., de Bree, L. C. J., Graumans, W., Stoter, R., van Gemert, G. J., van de Vegte-Bolmer, M., ... & Sauerwein, R. W. (2019). Outcomes of controlled human malaria infection after BCG vaccination. Nature communications, 10(1), 1-8.
Petherick, A. (2020). Developing antibody tests for SARS-CoV-2. The Lancet, 395(10230), 1101-1102.
Giefing‐Kröll, C., Berger, P., Lepperdinger, G., & Grubeck‐Loebenstein, B. (2015). How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging cell, 14(3), 309-321.
Conti, P., & Younes, A. (2020). Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents, 34(2), 339-343.
Zhou, C., Bu, G., Sun, Y., Ren, C., Qu, M., Gao, Y., ... & Liu, Y. (2020). Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay. Journal of Medical Virology.
Zhou, C., Bu, G., Sun, Y., Ren, C., Qu, M., Gao, Y., ... & Liu, Y. (2020). Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay. Journal of Medical Virology.
Wang, T., Chen, R., Liu, C., Liang, W., Guan, W., Tang, R., ... & Li, S. (2020). Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology, 7(5), e362-e363.
Raoult, D., Zumla, A., Locatelli, F., Ippolito, G., & Kroemer, G. (2020). Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell stress, 4(4), 66.
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020). Why does COVID-19 disproportionately affect older people?. Aging (Albany NY), 12(10), 9959..
Sotgiu, G., Barassi, A., Miozzo, M., Saderi, L., Piana, A., Orfeo, N., ... & Centanni, S. (2020). SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital. BMC Pulmonary Medicine, 20(1), 1-6.
Hou, H., Wang, T., Zhang, B., Luo, Y., Mao, L., Wang, F., ... & Sun, Z. (2020). Detection of IgM and IgG antibodies in patients with coronavirus disease 2019. Clinical & translational immunology, 9(5), e1136.
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., ... & Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature, 579(7798), 270-273.
Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281-292.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Dr. Anila Jaleel, MBBS, Ph.D, Dr Samar Asim, Dr. Kiran Namoos, Dr. Sadaf Saleem Uppal, Dr. Shahila Jaleel, Dr. Waqas Shabbir, Dr. Rukhshan Khursheed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
